Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × eravacycline × Clear all

NCT05537896 2024-04-11

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

Phase 2 Recruiting

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms